June 23, 2017

EnzBond awarded SynbiCITE funding


SynbiCITE has granted EnzBond £50,000 POC funding to develop a novel biocatalyst for the production of a blockbuster drug. Following the success of the project, this will be the first computation-only evolved enzyme applied to the production of a pharmaceutical compound on an industrial scale. The project will allow EnzBond to demonstrate its game-changing technology on the industrial target and will serve as a first step to develop a novel biocatalyst family for the highly desired reaction class.

December 6, 2016

EnzBond news on the Global University Venturing page


Read more on Oxford spins out EnzBond

December 2, 2016

EnzBond is officially incorporated

EnzBond Limited - a spin-out company from Oxford University has officially incorporated to bring fast, cost-effective enzyme development to market.

Read more on the Oxford University news page